AIP augments CARMA1-BCL10-MALT1 complex formation to facilitate NF-kappa B signaling upon T cell activation.
Cell Commun. Signal. 12:49 (2014)
Background: The CARMA1-BCL10-MALT1 (CBM) complex bridges T cell receptor (TCR) signaling to the canonical I kappa B kinase (IKK)/NF-kappa B pathway. The CBM complex constitutes a signaling cluster of more than 1 Mio Dalton. Little is known about factors that facilitate the rapid assembly and maintenance of this dynamic higher order complex. Findings: Here, we report the novel interaction of the aryl hydrocarbon receptor (AHR) interacting protein (AIP) and the molecular scaffold protein CARMA1. In T cells, transient binding of CARMA1 and AIP enhanced formation of the CBM complex. Thereby, AIP promoted optimal IKK/NF-kappa B signaling and IL-2 production in response to TCR/CD28 co-stimulation. Conclusions: Our data demonstrate that AIP acts as a positive regulator of NF-kappa B signaling upon T cell activation.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publication type
Article: Journal article
Document type
Scientific Article
Thesis type
Editors
Keywords
Immunology ; T Cell Signaling ; Canonical Nf-kappa B ; Maguk Family; Aryl-hydrocarbon Receptor; Guanylate Kinase Domains; Ah Receptor; Protein; Carma1; Phosphorylation; Xap2
Keywords plus
Language
english
Publication Year
2014
Prepublished in Year
HGF-reported in Year
2014
ISSN (print) / ISBN
1478-811X
e-ISSN
1478-811X
ISBN
Book Volume Title
Conference Title
Conference Date
Conference Location
Proceedings Title
Quellenangaben
Volume: 12,
Issue: 1,
Pages: ,
Article Number: 49
Supplement: ,
Series
Publisher
BioMed Central
Publishing Place
London
Day of Oral Examination
0000-00-00
Advisor
Referee
Examiner
Topic
University
University place
Faculty
Publication date
0000-00-00
Application date
0000-00-00
Patent owner
Further owners
Application country
Patent priority
Reviewing status
Peer reviewed
Institute(s)
Research Unit Signaling and Translation (SAT)
POF-Topic(s)
30203 - Molecular Targets and Therapies
Research field(s)
Enabling and Novel Technologies
PSP Element(s)
G-509800-002
Grants
Copyright
Erfassungsdatum
2014-09-01